<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03512145</url>
  </required_header>
  <id_info>
    <org_study_id>S61147</org_study_id>
    <nct_id>NCT03512145</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of the VIPUN Balloon Catheter 0.2 in Critically Ill Patients</brief_title>
  <acronym>ANTERO-2</acronym>
  <official_title>A Prospective Evaluation of the VIPUN Balloon Catheter 0.2: an Investigational Medical Device for the Monitoring of Gastric Motility in Adult Critically Ill Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Prof Dr Jan Tack</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      An open label, non-randomized, monocentric, interventional investigation in a cohort of adult
      critically ill patients
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 16, 2018</start_date>
  <completion_date type="Actual">August 30, 2019</completion_date>
  <primary_completion_date type="Actual">August 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gastric motility</measure>
    <time_frame>10 hours</time_frame>
    <description>Assessed with the VIPUN Balloon Catheter</description>
  </primary_outcome>
  <primary_outcome>
    <measure>gastric emptying rate</measure>
    <time_frame>6 hours</time_frame>
    <description>Assessed with 13C-octanoate breath test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Success rate placement and removal balloon catheter</measure>
    <time_frame>Day 0 until day 1 (&lt;24 h)</time_frame>
    <description>Success rate completing the procedures to place and remove the balloon catheter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety parameters potentially related to the use of the investigational medical device</measure>
    <time_frame>Day 0 until day 30</time_frame>
    <description>Incidence, frequency, severity, seriousness and relatedness of adverse events/effects are recorded.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Critical Illness</condition>
  <condition>Intolerance; Nutritional</condition>
  <condition>Delayed Gastric Emptying</condition>
  <condition>Gastric Motor Dysfunction</condition>
  <arm_group>
    <arm_group_label>VIPUN Balloon Catheter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Recording of gastric motility with the investigational medical device. Gastric emptying rate of a liquid meal is assessed with the 13C-octanoate breath test.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>VIPUN Balloon Catheter</intervention_name>
    <description>Gastric motility is recorded continuously with the VIPUN Balloon Catheter for 10 hours.</description>
    <arm_group_label>VIPUN Balloon Catheter</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Signed Informed Consent

          -  Of adult age (18 years or older)

          -  ICU patients in which enteral nutrition is planned to be initiated and are expected to
             stay at least 1 day in ICU on enteral feeding.

          -  Patients should be mechanically ventilated or have an endotracheal tube or
             tracheostomy in place.

        Exclusion Criteria:

          -  Contra-indication for (re-) placement of nasogastric feeding catheters.

          -  History of gastric or esophageal surgery

          -  Any gastrointestinal surgery or trauma that could significantly increase the risk
             related to the investigational medical device in the opinion of the investigator

          -  Fed by mouth or enterally prior to inclusion

          -  Patient is moribund

          -  Known pregnancy or breastfeeding women

          -  Receives gastroprokinetic medication (e.g., erythromycin, metoclopramide, domperidone)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospitals Leuven</name>
      <address>
        <city>Leuven</city>
        <state>Vlaams-Brabant</state>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>March 30, 2018</study_first_submitted>
  <study_first_submitted_qc>April 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 30, 2018</study_first_posted>
  <last_update_submitted>August 30, 2019</last_update_submitted>
  <last_update_submitted_qc>August 30, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Universitaire Ziekenhuizen Leuven</investigator_affiliation>
    <investigator_full_name>Prof Dr Jan Tack</investigator_full_name>
    <investigator_title>Member of staff hepato-gastroenterology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroparesis</mesh_term>
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

